Therapeutic Segment: Antihyperglycemic
“For the treatment of type 2 diabetes mellitus in adults:
-As monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance.
As dual oral therapy in combination with:
-Metformin, in patients with insufficient glycemic control despite maximal tolerated dose of monotherapy with Metformin.
-As triple oral therapy in combination with Sulfonylurea and Metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycemic control.
-Also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycemic control.”